Robert Chess, Director: Nektar Therapeutics NKTR Sell · Filed 23/09/20

Trade details

Type: Insider sale
Amount: $6,834
Shares · price: 10,200 sh · $0.67 a share
Held after: 274,773 sh
Stock: Nektar Therapeutics NKTR
Person: Robert ChessDirector
Trade date: 22/09/22
Filed: 23/09/20
Days to filing: 363 days

Sold 3.6% of holdings

Share of holding sold: 3.6%

Nektar Therapeutics trades, last 26 weeks

What else happened in Nektar Therapeutics around then

Filed or reported within 30 days of the trade day · 22/08/23~22/10/22

Robert Chess's recent trades

Robert ChessDirector
Planned sale10b5-1 planTwist Bioscience
Planned sale10b5-1 plan
Twist Bioscience
TWST
$2M
18,417 sh
$2M
Filed 08/07
Traded 08/07
Robert ChessDirector
Sell10b5-1 planTwist Bioscience
Sell10b5-1 plan
Twist Bioscience
TWST
$470K
10,000 sh
$470K
Filed 03/19
Traded 03/17
Robert ChessDirector
Planned sale10b5-1 planTwist Bioscience
Planned sale10b5-1 plan
Twist Bioscience
TWST
$470K
10,000 sh
$470K
Filed 03/17
Traded 03/17
Robert ChessDirector
SellTwist Bioscience
Sell
Twist Bioscience
TWST
$105.4K
2,184 sh
$105.4K
Filed 02/18
Traded 02/13
Robert ChessDirector
Planned saleTwist Bioscience
Planned sale
Twist Bioscience
TWST
$105.4K
2,184 sh
$105.4K
Filed 02/13
Traded 02/13